Precision Warheads: How Antibody–Drug Conjugates Are Redefining Lung Cancer Treatment
A comprehensive review details how antibody–drug conjugates targeting TROP2, HER2, c-MET, and other antigens are transforming non-small cell lung cancer ...
A comprehensive review details how antibody–drug conjugates targeting TROP2, HER2, c-MET, and other antigens are transforming non-small cell lung cancer ...
A new Chinese expert consensus provides detailed, evidence-graded guidance for managing the hematologic, gastrointestinal, pulmonary, hepatic, neurologic, and ocular side ...
New research in iScience reveals that the immune checkpoint molecule VSIR drives gastric cancer progression by transcriptionally activating and post-translationally ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine